JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 1. P.27–36
A.S. Krylov1, A.D. Ryzhkov1, S.V. Shiryaev1, M.O. Goncharov1, M.A. Krylova2, D.A. Komanovskaya1, M.E. Bilik1, S.M. Kaspshik1, E.M. Mikhailova1, E.E. Stanyakina1, A.G. Zhukov3
The Value of 99mTc-MIBI SPECT/CT Imaging in Evaluation of Head and Neck Cancer in Children
1. N.N. Blokhin National Medical Research Center, Moscow, Russia. E-mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.
2. Children’s City Polyclinic No. 11 of the Moscow City Health Department, Moscow, Russia
3. Clinical Hospital No. 52 Department of health of Moscow, Moscow, Russia
Abstract
Introduction: Head and neck cancers is a group of cancers that can vary in their histological form and localization. This disease has a high social significance thus it require well-timed and delicate approach, especially in children. We can improve the accuracy of diagnostic methods by using new algorithms and technologies. In this article we reveal the first experience of implementing 99mTc-MIBI SPECT/CT imaging for evaluation of head and neck cancer in children and introduce it as a routine method in Russia.
Purpose: Improve the diagnostic accuracy of head and neck cancer imagining in children by practical application of hybrid SPECT/CT method. Determine diagnostic value of planar scintigraphy and 99mTc-MIBI SPECT/CT of head and neck cancer in children.
Material and methods: This study was performed as a prospective clinical study. Between January 2017 and December 2017, 53 patients which met the inclusion criteria were examined. The inclusion criteria were patients with histologically proven malignancy, age 1–18, weight more than 10 kg, up to date CT or MRI scans (less than two weeks passed from scanning), for initial patients a tumor findings (more than 20 mm in the largest scale). We concluded 61 whole body planar scintigraphy followed by head and neck 99mTc-MIBI SPECT/CT examinations. 10 patients were examined twice, 1 patient was undergoing for this procedure for three times. Initial patients – 23, dynamic – 30. We performed scanning using a hybrid SPECT/CT after 15 minutes 99mTc-MIBI was injected. First stage was standard whole-body planar scintigraphy, second stage SPECT/CT (head and neck).
Results: We evaluated diagnostic accuracy of planar scintigraphy and 99mTc-MIBI SPECT/CT.
Planar scintigraphy sensitivity, specificity, NPV and PPV were 68.8, 96.6, 73.7, 95.7 %. SPECT/CT – 87.5, 96.6, 87.5, 96.6 %.
The verification method was histological examination or follow-up imagining (CT or MRI) during a 12 month period. Additional imagining using hybrid SPECT/CT method allows us to increase sensitivity and NPV of isotope scanning.
Most of false-negative results were obtained after planar scintigraphy, it can be related with image interpretation difficulties caused by equivocal image, especially, in patients during therapy. Six of such patients were correctly diagnosed with SPECT/CT and we revealed the presence of active tumor tissue.
With CT we additionally detected destruction of skull bones in 10 patients.
Conclusion: 1. Diagnostic accuracy of scintigraphy with 99mTc-MIBI is high: Sens. – 68.8 %. 2. We can increase diagnostic accuracy using hybrid methods, and so it plays an important role in final diagnosis: Sens. – 87.5 %, Spec. – 96.6 %. 3. SPECT/CT additionally detected destruction of skull bones even with negative scintigraphy results. 4. A strict clinical reasoning is needed in each individual case. 5. A further evaluation of the diagnostic capabilities of 99mTc-MIBI SPECT/CT in a larger number of patients appears justified.
Key words: SPECT/CT, 99mTc-MIBI, neck and head cancer, oncopediatry
For citation: Krylov AS, Ryzhkov AD, Shiryaev SV, Goncharov MO, Krylova MA, Komanovskaya DA, Bilik ME, Kaspshik SM, Mikhailova EM, Stanyakina EE, Zhukov AG. The Value of 99mTc-MIBI SPECT/CT Imaging in Evaluation of Head and Neck Cancer in Children. Medical Radiology and Radiation Safety. 2020;65(1):27-36. (In Russ.).
DOI: 10.12737/1024-6177-2020-65-1-27-36
Список литературы / References
- Злокачественные новообразования в России в 2015 г. Под ред. Каприна А.Д., Старинского В.В., Петровой Г.В. Московский научно-исследовательский онкологический институт им. П.А. Герцена. Москва. 2017. 250 с. [Malignant neoplasms in Russia in 2015. Caprin AD, Starinsky VV, Petrova GV (ed.). P.A. Herzen. Moscow Scientific Oncological Institute. Moscow, 2017, 250 p. (In Russ.)].
- Крылов АС. Радионуклидная диагностика злокачественных мезенхимальных опухолей мягких тканей у детей. Дисс. канд. мед. наук. Москва. 2011. 150 с. [Krylov AS. Radionuclide diagnostics of malignant mesenchymal tumors of soft tissues in children. PhD Med. Moscow, 2011, 150 p. (In Russ.)].
- Крылов АС, Поляков ВГ, Ширяев СВ. Оценка эффективности лечения сарком мягких тканей у детей при помощи сцинтиграфии с 99mTc-технетрилом и 67Ga-цитратом. Онкопедиатрия. 2014(2):42-8. [Krylov AS, Polyakov VG, Shiryaev SV. Estimation of efficiency of treatment of children’s soft tissues sarcomas using 99mTc-mibi and 67Ga-citrate scintigraphy. Oncopediatria. 2014(2):42-8. (In Russ.)].
- Алтынбаева ЛР, Габдрахманова АФ. Современные радионуклидные методы в диагностике объёмных образований орбиты. Казанский медицинский журнал. 2015;96(3):381-4. DOI: 10.17750/KMJ2015-381. [Altynbaeva LR, Gabdrakhmanova AF. Modern radionuclide methods in diagnosing orbital masses. Kazan Medical Journal. 2015;96(3):381-4. DOI: 10.17750/KMJ2015-381. (In Russ.)].
- Крылов АС, Ширяев СВ, Поляков ВГ и др. Сравнительная оценка возможности сцинтиграфии с 67Ga-цитратом и 99mTc-технетрилом при злокачественных мезенхимальных опухолях мягких тканей у детей. Медицинская радиология и радиационная безопасность. 2010;55(3):63-8. [Krylov AS, Shiryaev SV, Polyakov VG, et al. The Comparative Assessment of 99mTc-MIBI and 67Ga-citrate Scintigraphy in Children’s Malignant Mesenchymal Tumors of Soft Tissues. Мedical Radiology and Radiation Safety. 2010;55(3):63-8. (In Russ.)].
- Крылов АС, Ширяев СВ, Рыжков АД и др. ОФЭКТ/РКТ с 99mTc-технетрилом в мониторинге эстезионейробластомы. Сибирский онкологический журнал. 2017;16(2):97-102. DOI: 10.21294/1814-4861-2017-16-2-97-102. [Krylov AS, Shiryaev SV, Ryzhkov AD, et al. SPECT/CT with 99mTс-MIBI in monitoring of esthesioneuroblastoma. Siberian Journal of Oncology. 2017;16(2):97-102. DOI: 10.21294/1814-4861-2017-16-2-97-102. (In Russ.)].
- Kirton A, Kloiber R, Rigel J, Wolff J. Evaluation of Pediatric CNS Malignancies with 99mTc-methoxyisobutylisonitrile SPECT. J Nucl Med. 2002;43(11):1438-43.
- Sobic-Saranovic DP, Pendjer IP, Kozarevic NDj, et al. Evaluation of undifferentiated carcinoma of nasopharyngeal type with thallium-201 and technetium-99m MIBI SPECT. Otolaryngology–Head and Neck Surgery. 2007;137(3):405-11. DOI: 10.1016/j.otohns.2007.03.026.
- Чернов ВИ, Зельчан РВ, Тицкая АА и др. Однофотонная эмиссионная компьютерная томография с 99mTс-МИБИ и 199Tl-хлоридом в диагностике и оценке эффективности химиотерапии первичных и рецидивных опухолей гортани и гортаноглотки./ Молекулярная медицина. 2013(4):26-30. [Chernov VI, Zelchan RV, Titskaya AA, et al. Single photon emission computed tomography with 99mTc-MIBI and 199Tl-chloride in the diagnosis and evaluation of the effectiveness of chemotherapy of primary and recurrent tumors of the larynx and hypopharynx. Molecular Medicine. 2013(4):26-30. (In Russ.)].
- Чернов ВИ, Зельчан РВ, Тицкая АА и др. Применение гамма-сцинтиграфии с 99mTc-технетрилом в комплексной диагностике и оценке эффективности неоадъювантной химиотерапии злокачественных опухолей гортани и гортаноглотки. Медицинская радиология и радиационная безопасность. 2011;56(2):38-43. [Chernov VI, Zelchan RV, Titskaya AA, et al. Gamma Scintigraphy with 99mTc-MIBI in the Complex Diagnostics and Assessment of Neoadjuvant Chemotherapy Efficacy in Laryngeal and Laryngopharyngeal Cancers. Мedical Radiology and Radiation Safety. 2011;56(2):38-43. (In Russ.)].
- Leitha T, Glaser C, Pruckmayer M, et al. Technetium-99m-MIBI in Primary and Recurrent Head and Neck Tumors: Contribution of Bone SPECT Image Fusion. J Nucl Med. 1998;39(7):1166-71.
- Tuli HS, Singh B, Prasad V, et al. Diagnostic accuracy of 99mTc-MIBI-SPECT in the detection of lymph node metastases in patients with carcinoma of the tongue: comparison with computed tomography and MRI. Nucl Med Commun. 2008;29(9):803-8. DOI: 10.1097/MNM.0b013e328302ccfa.
- Tomura N, Watanabe O, Takahashi S, et al. Comparison of 201Tl-chloride SPECT with 99mTc-MIBI SPECT in the depiction of malignant head and neck tumors. Ann Nucl Med. 2006;20(2):107-14.
- Tomura N, Hirano H, Watanabe O, et al. Evaluation of single photon emission computed tomography of tumors in the head and neck with technetium-99m MIBI. Kaku Igaku. 1997;34(7):471-9.
- Крылов АС, Билик МЕ, Комановская ДА и др. Роль ОФЭКТ/КТ c 99mTc-технетрилом в диагностике злокачественных опухолей головы и шеи у детей. Материалы IV Петербургского международного онкологического форума «Белые ночи 2018», 5–8 июля, Санкт-Петербург, 139 c. [Krylov AS, Ryzhkov AD, Shiryaev SV, et al. The role of 99mTc‑MIBI SPECT/CT in the diagnosis of malignant tumors of the head and neck in children. In the book: Proceedings of the IV St. Petersburg International Oncological Forum “White Nights 2018”, July 5-8, St. Petersburg, 139 p. (In Russ.)].
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Informed consent. Parents of patients signed an informed consent for their children to participate in the study.
Article received: 30.10.2019. Accepted for publication: 11.12.2019